LEGN Legend Biotech Corporation - American Depositary Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Mar 10, 2026
$18.57
· of 52w range
· above low
· to high
$16.2552w low
$37.5052w high
P/E
-26.8
EPS
$-0.81
Revenue
$627M
your badges
52W Range
$16–$38
Analyst Rating
BUY
Price Target
$46
P/E
-26.8
ROE
-29.1%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
LEGN Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$18.57
P/E
-26.8
EPS
$-0.81
Revenue
$627M
ROE
-29.1%
52W Range
$16–$38
LEGN Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$627M2018-12-31 → 2024-12-31
EPS$-0.812018-12-31 → 2025-12-31
Free Cash Flow$-129M2020-12-31 → 2025-12-31
Net margin·2020-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | LEGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -26.85Y avg ≈-40.8 | ≈-40.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | LEGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -17.4%5Y avg ≈-28.1% | ≈-28.1% | -22.9% | Top tier | |
| ROE | -29.1%5Y avg ≈-43.0% | ≈-43.0% | -35.6% | Top tier | |
| ROIC | -14.3% | · | -14.3% | In line |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | LEGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio | 2.05Y avg ≈4.3 | ≈4.3 | 9.2 | Low liquidity | |
| Quick Ratio | 1.55Y avg ≈3.6 | ≈3.6 | 5.6 | Low liquidity | |
| Interest Coverage | -6.4 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | LEGN | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Inventory Turnover | 14.25Y avg ≈11.2 | ≈11.2 | · | · | |
| Revenue / Employee | ≈$196.0K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-245.2%
Next Report
Nov 10, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 11, 2026 | $0.18 | $0.08 | 135.6% |
| March 31, 2026 | May 11, 2026 | $-0.30 | $-0.02 | -1295.3% |
| Dec. 31, 2025 | $-0.16 | $-0.11 | -44.5% | |
| Sept. 30, 2025 | $-0.22 | $-0.09 | -155.5% | |
| June 30, 2025 | $-0.68 | $-0.15 | -366.1% | |
| March 31, 2025 | $-0.54 | $-0.23 | -137.4% | |
| Dec. 31, 2024 | $0.15 | $-0.32 | 147.1% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | · | $627M | $285M | $117M | $69M | $75M | $60M | |
| Cost of Revenue | $397M | $216M | $144M | $65M | $0 | $0 | · | |
| R&D Expense | $415M | $414M | $382M | $336M | $313M | $232M | $162M | |
| Operating Income | $-136M | $-310M | $-528M | · | · | · | · | |
| Interest Expense | $21M | $22M | $22M | $11M | $900.0K | $4M | $223.0K | |
| Interest Income | $40M | $61M | $54M | $8M | $971.0K | $3M | $5M | |
| Pretax Income | $-283M | $-158M | $-520M | $-446M | $-407M | $-308M | $-127M | |
| Income Tax | $14M | $19M | $-2M | $625.0K | $-4M | $-42M | $-26M | |
| Net Income | $-297M | $-177M | $-518M | $-446M | $-404M | $-266M | $-102M | |
| EPS (Basic) | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 | $-1.13 | $-0.51 | |
| EPS (Diluted) | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 | $-1.13 | $-0.51 | |
| Shares (Basic) | 368,641,170 | 365,702,143 | 352,165,418 | 318,083,913 | 281,703,291 | 236,305,234 | 200,000,000 | |
| Shares (Diluted) | 368,641,170 | 365,702,143 | 352,165,418 | 318,083,913 | · | · | · | |
| EBITDA | $-136M | · | · | · | · | · | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $949M | $1.13B | $1.31B | $841M | $859M | $506M | $159M | |
| Inventory | $32M | $24M | $19M | $10M | $2M | $2M | $1M | |
| Current Assets | $1.25B | $1.28B | $1.50B | $1.10B | $950M | $594M | $207M | |
| PP&E (Net) | $116M | $99M | $109M | $105M | $103M | $72M | $45M | |
| Intangibles | $2M | $2M | $4M | $3M | $5M | $3M | $519.0K | |
| Total Assets | $1.73B | $1.67B | $1.85B | $1.33B | $1.12B | $722M | $288M | |
| Current Liabilities | $636M | $278M | $216M | $298M | $229M | $116M | $128M | |
| Total Liabilities | $732M | $630M | $597M | $587M | $354M | $124M | $411M | |
| Retained Earnings | · | · | · | · | $471M | $280M | $-123M | |
| Stockholders' Equity | $1.00B | $1.04B | $1.25B | $744M | $766M | $598M | $-123M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $-100M | $-144M | $-393M | $-201M | $-198M | $-223M | $-83M | |
| CapEx | $29M | $14M | $20M | $21M | $42M | $26M | $27M | |
| Investing Cash Flow | $710M | $-851M | $93M | $-77M | $-195M | $-24M | $-59M | |
| Financing Cash Flow | $-300.0K | $6M | $791M | $378M | $627M | $619M | $15M | |
| Free Cash Flow | $-129M | $-158M | $-413M | $-222M | $-241M | $-269M | · | |
| Levered FCF | $-151M | $-182M | $-435M | $-233M | $-242M | $-273M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Net Margin | · | -28.2% | -181.8% | -381.5% | -586.4% | -401.0% | · | |
| Pretax Margin | · | -25.2% | -182.4% | -380.9% | -591.6% | -406.5% | · | |
| ROA | -17.4% | -10.1% | -32.6% | -36.4% | -43.8% | -59.9% | · | |
| ROE | -29.1% | -15.4% | -51.9% | -59.1% | -59.2% | -140.6% | · | |
| ROIC | -14.3% | · | · | · | · | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | 4.6 | 6.9 | 3.7 | 4.1 | 3.7 | · | |
| Quick Ratio | 1.5 | 4.1 | 6.1 | 2.8 | 3.7 | 3.1 | · | |
| Interest Coverage | -6.4 | · | · | · | · | · | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 0.4 | 0.2 | 0.1 | 0.1 | 0.1 | · | |
| Inventory Turnover | 14.2 | 10.0 | 9.7 | 10.8 | · | · | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue / Share | · | $1.72 | · | · | · | · | · | |
| Cash Flow / Share | $-0.27 | $-0.39 | · | · | · | · | · | |
| EPS (TTM) | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 | $-1.13 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $627M | $285M | $117M | $69M | $75M | · | |
| Net Income TTM | $-297M | $-177M | $-518M | $-446M | $-404M | $-266M | · | |
| P/E | -26.8 | -67.8 | -40.9 | -35.7 | -32.6 | -24.9 | · | |
| Earnings Yield | -3.7% | -1.5% | -2.4% | -2.8% | -3.1% | -4.0% | · |
No quarterly filings for LEGN
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | · | $627M | $285M | $117M | $69M |
| Net Income | $-297M | $-177M | $-518M | $-446M | $-404M |
| Diluted EPS | $-0.81 | $-0.48 | $-1.47 | $-1.40 | $-1.43 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | 2.0 | 4.6 | 6.9 | 3.7 | 4.1 |
| Quick Ratio | 1.5 | 4.1 | 6.1 | 2.8 | 3.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $-129M | $-158M | $-413M | $-222M | $-241M |
Institutional owners (13F) 236 filers · $3.0B total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
236
Value held
$3.0B
New positions
57
Exited positions
25
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 57 (+23 vs prior Q) | 25 (-14 vs prior Q) | 67 (-15 vs prior Q) | 79 (+23 vs prior Q) | +6.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| FMR LLC | $840,231,809 | 29,093,899 | 28.04% | Shares |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $235,014,985 | 8,137,638 | 7.84% | Shares |
| MONTANOVA CAPITAL, LLC | $204,181,600 | 7,070,000 | 6.81% | Shares |
| HHLR ADVISORS, LTD. | $172,833,804 | 5,984,550 | 5.77% | Shares |
| BlackRock, Inc. | $136,502,311 | 4,726,534 | 4.56% | Shares |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $127,940,224 | 4,430,063 | 4.27% | Shares |
| GOLDMAN SACHS GROUP INC | $105,767,658 | 3,662,315 | 3.53% | Shares |
| Point72 Asset Management, L.P. | $88,838,461 | 3,076,124 | 2.96% | Shares |
| Kynam Capital Management, LP | $86,674,800 | 3,001,205 | 2.89% | Shares |
| Assenagon Asset Management S.A. | $55,306,817 | 1,915,056 | 1.85% | Shares |
| Artisan Partners Limited Partnership | $45,036,656 | 1,559,441 | 1.50% | Shares |
| STATE STREET CORP | $43,291,671 | 1,498,704 | 1.44% | Shares |
| Capital International Investors | $41,028,488 | 1,420,654 | 1.37% | Shares |
| MORGAN STANLEY | $40,274,080 | 1,394,531 | 1.34% | Shares |
| Soleus Capital Management, L.P. | $34,800,400 | 1,205,000 | 1.16% | Shares |
| Davern Capital Partners, LP | $34,411,155 | 1,191,522 | 1.15% | Shares |
| Driehaus Capital Management LLC | $33,466,375 | 1,158,808 | 1.12% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $28,885,776 | 1,000,200 | 0.96% | Shares |
| Ghisallo Capital Management LLC | $28,880,000 | 1,000,000 | 0.96% | Shares |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | $26,490,642 | 917,266 | 0.88% | Shares |
| JOHNSON & JOHNSON | $23,525,244 | 814,586 | 0.79% | Shares |
| IvyRock Asset Management (HK) Ltd | $23,132,880 | 801,000 | 0.77% | Shares |
| EcoR1 Capital, LLC | $23,104,000 | 800,000 | 0.77% | Shares |
| JPMORGAN CHASE & CO | $22,523,437 | 766,364 | 0.75% | Shares |
| Squarepoint Ops LLC | $22,215,998 | 769,252 | 0.74% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $21,948,627 | 759,994 | 0.73% | Shares |
| Woodline Partners LP | $19,149,924 | 663,086 | 0.64% | Shares |
| Triata Capital Ltd | $18,191,916 | 629,914 | 0.61% | Shares |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $17,328,000 | 600,000 | 0.58% | Shares |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $16,596,903 | 574,685 | 0.55% | Shares |
| Elmind Capital, LP | $16,478,033 | 570,569 | 0.55% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $16,157,962 | 563,489 | 0.54% | Shares |
| TWO SIGMA ADVISERS, LP | $14,991,904 | 689,600 | 0.50% | Shares |
| Candriam S.C.A. | $14,568,175 | 504,924 | 0.49% | Shares |
| UBS Group AG | $14,511,218 | 502,466 | 0.48% | Shares |
| CenterBook Partners LP | $13,079,954 | 452,907 | 0.44% | Shares |
| ArrowMark Colorado Holdings LLC | $10,477,115 | 362,781 | 0.35% | Shares |
| Hudson Bay Capital Management LP | $9,819,200 | 340,000 | 0.33% | Shares |
| Alyeska Investment Group, L.P. | $8,879,849 | 307,474 | 0.30% | Shares |
| Empire Life Investments Inc. | $8,565,404 | 296,586 | 0.29% | Shares |
| NORTHERN TRUST CORP | $7,937,842 | 274,856 | 0.26% | Shares |
| Resolute Capital Asset Partners LLC | $7,533,954 | 260,871 | 0.25% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $7,261,847 | 251,449 | 0.24% | Shares |
| Burkehill Global Management, LP | $7,220,000 | 250,000 | 0.24% | Shares |
| AMERIPRISE FINANCIAL INC | $7,213,272 | 249,767 | 0.24% | Shares |
| Invesco Ltd. | $7,159,409 | 247,902 | 0.24% | Shares |
| HSBC HOLDINGS PLC | $6,820,611 | 236,204 | 0.23% | Shares |
| Legal & General Group Plc | $6,580,800 | 227,867 | 0.22% | Shares |
| Longaeva Partners L.P. | $6,190,572 | 214,355 | 0.21% | Shares |
| Balyasny Asset Management L.P. | $6,093,564 | 210,996 | 0.20% | Shares |
Company insiders 10 insiders · 4 officers · 7 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Ingrid Zhang | Chief Executive Officer | Sept. 15, 2026 A | 1,131,860 | 0 | 0 | $0 |
| Alan Bash | Interim CEO | Aug. 14, 2026 A | 35,142 | 0 | 0 | $0 |
| Ying Huang | Chief Executive Officer | June 30, 2026 G | 238,490 | 0 | 2 | $-169,404 |
| Carlos E Santos | Chief Financial Officer | Sept. 21, 2026 S | 14,246 | 0 | 1 | $-49,630 |
| Corazon (Corsee) D. Sanders | Director | Sept. 29, 2026 S | 52,731 | 0 | 1 | $-258,920 |
| Li Mao | Director | Sept. 24, 2026 A | 65,316 | 0 | 0 | $0 |
| Peter Salovey | Director | Sept. 24, 2026 A | 55,096 | 0 | 0 | $0 |
| Patrick John Casey | Director | Sept. 24, 2026 A | 69,590 | 0 | 1 | $-88,800 |
| Darren Xiaohui Ji | Director | Sept. 24, 2026 A | 92,103 | 0 | 0 | $0 |
| Tomas J. Heyman | Director | Sept. 24, 2026 A | 53,720 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 17 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| PBE · Invesco Exchange-Traded Fund Trust | 2.58% | 550,910 SH | Oct. 1, 2026 | Daily |
| MEDI · Harbor ETF Trust | 1.91% | 42,415 NS | July 31, 2026 | N-PORT |
| BBP · ETFis Series Trust I | 0.71% | 37,834 NS | July 31, 2026 | N-PORT |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0.31% | 1,539 NS | July 31, 2026 | N-PORT |
| IBB · iShares Trust | 0.21% | 1,132,518 SH | Sept. 11, 2026 | Daily |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0.12% | 6,507 SH | Oct. 1, 2026 | Daily |
| ESIM · Strategy Shares | 0.07% | 655 NS | July 31, 2026 | N-PORT |
| MCHI · iShares Trust | 0.06% | 185,824 SH | Sept. 11, 2026 | Daily |
| BKF · iShares, Inc. | 0.03% | 1,184 SH | Sept. 11, 2026 | Daily |
| EEMA · iShares, Inc. | 0.02% | 10,243 SH | Sept. 11, 2026 | Daily |
| FBCG · FIDELITY COVINGTON TRUST | 0.02% | 68,015 NS | July 31, 2026 | N-PORT |
| AAXJ · iShares Trust | 0.01% | 29,070 SH | Sept. 11, 2026 | Daily |
| EEM · iShares, Inc. | 0.01% | 186,106 SH | Sept. 11, 2026 | Daily |
| IEMG · iShares, Inc. | 0.01% | 839,899 SH | Sept. 11, 2026 | Daily |
| ACWX · iShares Trust | 0.00% | 24,903 SH | Sept. 11, 2026 | Daily |
| IXUS · iShares Trust | 0.00% | 118,403 SH | Sept. 11, 2026 | Daily |
| ACWI · iShares Trust | 0.00% | 18,110 SH | Sept. 11, 2026 | Daily |
LEGN Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 23 analysts
BUY
Median target
$48.00
+158.5%
6 26.1%
Strong Buy
11 47.8%
Buy
6 26.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
13 analysts · 2026-10-02Mean target $46.50 +150.4%
← Below all targets
Current price $18.57
Low$24.00
Mean$46.50
High$74.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| LEGN | · | -26.8 | · | · | -29.1% | · |
| RLAY | $1.47B | -5.3 | 53.4% | -1800.6% | -44.9% | · |
| TNGX | $1.20B | -10.2 | 48.3% | -162.8% | -42.2% | · |
| VKTX | $4.04B | -11.0 | · | · | -47.3% | · |
| VCYT | $3.34B | 51.3 | 16.0% | 12.8% | 5.2% | 70.1% |
| IDYA | $3.04B | -27.0 | 3024.4% | -52.0% | -11.5% | · |
| PBLS | · | · | · | · | · | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
Latest News Recent headlines mentioning this company
Legend Biotech (LEGN) Soars 42% on Promising Cancer Therapy Results
Yahoo Finance · 3 months, 4 weeks ago
Legend Biotech (LEGN) Trims Losses, Shares Climb Double-Digits
Yahoo Finance · 4 months, 2 weeks ago
Legend Biotech (LEGN) Gets Bullish Ratings, PT Hike, Soars 18%
Yahoo Finance · 5 months, 1 week ago
Why Legend Biotech Stock Crushed the Market on Monday
Nasdaq · 5 months, 1 week ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Mar 10, 2026